These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 38493153)

  • 41. A two-step stimulus-response cell-SELEX method to generate a DNA aptamer to recognize inflamed human aortic endothelial cells as a potential in vivo molecular probe for atherosclerosis plaque detection.
    Ji K; Lim WS; Li SF; Bhakoo K
    Anal Bioanal Chem; 2013 Aug; 405(21):6853-61. PubMed ID: 23842900
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Artificial Intelligence in Aptamer-Target Binding Prediction.
    Chen Z; Hu L; Zhang BT; Lu A; Wang Y; Yu Y; Zhang G
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808496
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Post-SELEX optimization of aptamers.
    Gao S; Zheng X; Jiao B; Wang L
    Anal Bioanal Chem; 2016 Jul; 408(17):4567-73. PubMed ID: 27173394
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development of a Single Stranded DNA Aptamer as a Molecular Probe for LNCap Cells Using Cell-SELEX.
    Almasi F; Mousavi Gargari SL; Bitaraf F; Rasoulinejad S
    Avicenna J Med Biotechnol; 2016; 8(3):104-11. PubMed ID: 27563422
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The application of Aptamer in biomarker discovery.
    Li Y; Tam WW; Yu Y; Zhuo Z; Xue Z; Tsang C; Qiao X; Wang X; Wang W; Li Y; Tu Y; Gao Y
    Biomark Res; 2023 Jul; 11(1):70. PubMed ID: 37468977
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Research advances in the role of aptamers in the diagnosis and targeted therapy of pediatric cancer].
    Zhang YB; Wang YP; Liu J
    Zhongguo Dang Dai Er Ke Za Zhi; 2018 May; 20(5):421-427. PubMed ID: 29764582
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oligonucleotide aptamers: Recent advances in their screening, molecular conformation and therapeutic applications.
    Xiao X; Li H; Zhao L; Zhang Y; Liu Z
    Biomed Pharmacother; 2021 Nov; 143():112232. PubMed ID: 34649356
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Aptamer selection and applications for breast cancer diagnostics and therapy.
    Liu M; Yu X; Chen Z; Yang T; Yang D; Liu Q; Du K; Li B; Wang Z; Li S; Deng Y; He N
    J Nanobiotechnology; 2017 Nov; 15(1):81. PubMed ID: 29132385
    [TBL] [Abstract][Full Text] [Related]  

  • 49. SELEX methods on the road to protein targeting with nucleic acid aptamers.
    Bayat P; Nosrati R; Alibolandi M; Rafatpanah H; Abnous K; Khedri M; Ramezani M
    Biochimie; 2018 Nov; 154():132-155. PubMed ID: 30193856
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Unraveling Prion Protein Interactions with Aptamers and Other PrP-Binding Nucleic Acids.
    Macedo B; Cordeiro Y
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28513534
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Advanced cancer targeting using aptamer functionalized nanocarriers for site-specific cargo delivery.
    Narwade M; Shaikh A; Gajbhiye KR; Kesharwani P; Gajbhiye V
    Biomater Res; 2023 May; 27(1):42. PubMed ID: 37149607
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aptamers and Antisense Oligonucleotides for Diagnosis and Treatment of Hematological Diseases.
    Giudice V; Mensitieri F; Izzo V; Filippelli A; Selleri C
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32375354
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bioapplications of Cell-SELEX-Generated Aptamers in Cancer Diagnostics, Therapeutics, Theranostics and Biomarker Discovery: A Comprehensive Review.
    Pang X; Cui C; Wan S; Jiang Y; Zhang L; Xia L; Li L; Li X; Tan W
    Cancers (Basel); 2018 Feb; 10(2):. PubMed ID: 29425173
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Advances in Aptamer-Based Biosensors and Cell-Internalizing SELEX Technology for Diagnostic and Therapeutic Application.
    Gan Z; Roslan MAM; Abd Shukor MY; Halim M; Yasid NA; Abdullah J; Md Yasin IS; Wasoh H
    Biosensors (Basel); 2022 Oct; 12(11):. PubMed ID: 36354431
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro evolution of chemically-modified nucleic acid aptamers: Pros and cons, and comprehensive selection strategies.
    Lipi F; Chen S; Chakravarthy M; Rakesh S; Veedu RN
    RNA Biol; 2016 Dec; 13(12):1232-1245. PubMed ID: 27715478
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Aptamers in hematological malignancies and their potential therapeutic implications.
    Ouyang W; Yu Z; Zhao X; Lu S; Wang Z
    Crit Rev Oncol Hematol; 2016 Oct; 106():108-17. PubMed ID: 27637356
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nucleic Acid Aptamers as Potential Therapeutic and Diagnostic Agents for Lymphoma.
    Shum KT; Zhou J; Rossi JJ
    J Cancer Ther; 2013 Jun; 4(4):872-890. PubMed ID: 25057429
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Aptamers selected by cell-SELEX for application in cancer studies.
    Zhang Y; Chen Y; Han D; Ocsoy I; Tan W
    Bioanalysis; 2010 May; 2(5):907-18. PubMed ID: 20657791
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Conjugate-SELEX: A High-throughput Screening of Thioaptamer-liposomal Nanoparticle Conjugates for Targeted Intracellular Delivery of Anticancer Drugs.
    Mu Q; Annapragada A; Srivastava M; Li X; Wu J; Thiviyanathan V; Wang H; Williams A; Gorenstein D; Annapragada A; Vigneswaran N
    Mol Ther Nucleic Acids; 2016 Nov; 5(10):e382. PubMed ID: 27802264
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nucleic acid aptamer application in diagnosis and therapy of colorectal cancer based on cell-SELEX technology.
    Chen C; Zhou S; Cai Y; Tang F
    NPJ Precis Oncol; 2017; 1(1):37. PubMed ID: 29872716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.